GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises ...

Learn more about whether Glaukos Corporation or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ ...

On its fourth-quarter earnings call, Glaukos highlighted the increasing adoption of iStent Infinite for glaucoma patients, particularly those unresponsive to other treatments. This growth has been ...

Minimally invasive glaucoma surgeries, like the iStent inject and Xen Gel Stent, are crucial for preventing disease progression. Technological innovations, including AI-driven diagnostics and ...

The relatively new surgical method is safer, less traumatic and sees fewer complications than traditional treatment options ...

Learn more about whether Glaukos Corporation or iRhythm Technologies, Inc. is a better investment based on AAII's A+ Investor ...

It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma.